Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients

doi:10.1186/1471-2334-6-137

BMC Infectious Diseases

Volume 6

Viewing options:

Abstract
Full text
PDF (326KB)
Additional files

Associated material:

Related literature:

Articles citing this article
on BioMed Central
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Ruotsalainen E
Sammalkorpi K
Laine J
Huotari K
Sarna S
Valtonen V
Järvinen A

on PubMed

Ruotsalainen E
Sammalkorpi K
Laine J
Huotari K
Sarna S
Valtonen V
Järvinen A
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Research article

Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients

Eeva Ruotsalainen¹ , Kari Sammalkorpi¹ , Janne Laine² , Kaisa Huotari¹ , Seppo Sarna³ , Ville Valtonen¹ and Asko Järvinen¹

¹Division of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland

²Department of Medicine, Tampere University Hospital, Tampere, Finland

³Department of Public Health, University of Helsinki, Helsinki, Finland

author email corresponding author email

BMC Infectious Diseases 2006, 6:137doi:10.1186/1471-2334-6-137


Published:	11 September 2006

Additional files

Additional file 1:

Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: A prospective and randomized clinical trial of 381 patients. This article represents original trial where the effect of levofloxacin in addition to standard antistaphylococcal treatment of SAB was studied in relation to patient outcome and development of complications.

Format: PDF Size: 145KB Download file

This file can be viewed with: Adobe Acrobat Reader